Emergent BioSolutions, Inc. (EBS)
11.41
+0.31
(+2.79%)
USD |
NYSE |
Jan 21, 12:42
Emergent BioSolutions Total Liabilities (Quarterly): 878.50M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp. | 19.08B |
| Eli Lilly & Co. | 91.08B |
| Penumbra, Inc. | 385.67M |
| Disc Medicine, Inc. | 57.06M |
| Black Diamond Therapeutics, Inc. | 31.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.461B |
| Shareholders Equity (Quarterly) | 582.50M |
| Debt to Equity Ratio | 1.152 |
| Current Ratio | 5.765 |
| Net Debt Paydown Yield | 8.86% |